tiprankstipranks
Trending News
More News >
CTT Pharmaceutical Holdings Inc (CTTH)
OTHER OTC:CTTH
US Market

CTT Pharmaceutical Holdings (CTTH) Income Statement

Compare
9 Followers

CTT Pharmaceutical Holdings Income Statement

Last quarter (Q2 2025), CTT Pharmaceutical Holdings's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, CTT Pharmaceutical Holdings's net income was $-7.27K. See CTT Pharmaceutical Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -6.40K$ -6.40K$ -6.40K$ 0.00$ 0.00
Operating Expenses
$ 243.83K$ 35.70K$ 102.41K$ 148.45K$ 584.31K
Depreciation and Amortization
$ 6.40K$ 6.40K$ 6.40K$ 236.56K$ 206.30K
EBITDA
$ -243.83K$ -35.70K$ -44.71K$ 103.56K$ -379.70K
Operating Income
$ -250.00K$ -42.09K$ -109.00K$ -148.00K$ -584.00K
Other Income/Expenses
$ 40.00K$ -125.00$ 55.35K$ 15.38K$ -2.04K
Pretax Income
$ -210.00K$ -42.22K$ -53.45K$ -133.00K$ -586.00K
Net Income
$ -210.00K$ -42.22K$ -53.45K$ -133.00K$ -586.00K
Per Share Metrics
Basic EPS
$ 0.00$ 0.00$ 0.00$ 0.00$ -0.01
Diluted EPS
$ 0.00$ 0.00$ 0.00$ 0.00$ -0.01
Weighted Average Shares Outstanding
52.40M 50.53M 49.42M 50.07M 47.57M
Weighted Average Shares Outstanding (Diluted)
52.40M 50.53M 49.42M 50.07M 47.57M
Currency in USD

CTT Pharmaceutical Holdings Earnings and Revenue History